Top Markets
#1 DogBull DogBull +106.81%
#2 ADO Protocol ADO Protocol +51.25%
#3 Siacoin Siacoin +43.26%
#4 The Bitcoin Bull The Bitcoin Bull +40.20%
#5 MarsCoin MarsCoin +38.85%
#6 UnifAI Network UnifAI Network +26.18%
#7 Ontology Gas Ontology Gas +25.81%
#8 Glidr Glidr +25.19%
#9 Useless Coin Useless Coin +18.74%
#10 Falcon Finance Falcon Finance +17.94%
Coin of the day
DogBull DogBull
Settings
Language
ENGLISH
Currency
USD
Theme
AbClon Inc. AbClon Inc.

AbClon Inc.

174900
Rank in Stocks #15855
Founded in Seoul, South Korea, in 2010, AbClon Inc. is a biopharmaceutical... Founded in Seoul, South Korea, in 2010, AbClon Inc. is a biopharmaceutical company engaged in the discovery and development of antibody-based drugs, with operations spanning South Korea and Sweden. The firm's developmental pipeline encompasses therapies derived from distinct technological platforms: the NEST platform addresses breast and gastric cancers; the AffiMab platform targets colon cancer and various autoimmune conditions; and the CAR-T platform is engineered for hematologic and ovarian cancers.
Share Price
$16.42
Market Cap
$327.24M
Change (1 day)
-3.46%
Change (1 year)
129.62%
Country
KR
Trade AbClon Inc. (174900)

Category

Healthcare
P/S ratio for AbClon Inc. (174900)
P/S ratio as of 2026 TTM: 0
According to AbClon Inc. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for AbClon Inc. from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.95 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
12.19 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
24.99 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.75 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH